- Part 2 covers federally assisted SUD programs, and "federally assisted" includes Medicare participation, a DEA registration used for SUD treatment, federal funds and tax-exempt status.
- A Part 2 consent form has required elements, and SUD counseling notes need a separate consent of their own.
- Since the 2024 rule, one consent can cover all future treatment, payment and operations, and HIPAA entities that receive records under it may share them again as HIPAA allows.
- Records still cannot be used in legal proceedings against the patient without specific consent or a court order.
What is 42 CFR Part 2?
42 CFR Part 2, usually just "Part 2", is the federal regulation on the confidentiality of substance use disorder patient records. In SAMHSA's words, Part 2 is a federal law "that protects the confidentiality of patient records for people receiving services for substance use disorders (SUDs)" (SAMHSA). It sits in Title 42 of the Code of Federal Regulations, hence "title 42 CFR part 2". The statute behind it is 42 U.S.C. 290dd-2.
The regulation states its own purpose: to ensure that a patient in a Part 2 program "is not made more vulnerable by reason of the availability of their record than an individual with a substance use disorder who does not seek treatment" (42 CFR 2.2). Fear of exposure keeps people out of treatment, so these records get tighter protection than most health records.
The 42 CFR Part 2 regulations have subparts for general provisions, uses with consent (including "the consent form requirements"), uses without consent, and court orders (42 CFR 2.2). This page is general information, not legal advice.
Who does 42 CFR Part 2 apply to?
Part 2 applies to a "part 2 program", which the rule defines as "a federally assisted program" (42 CFR 2.11). Both words matter. A program is a person or unit that "holds itself out as providing, and provides, substance use disorder diagnosis, treatment, or referral for treatment". A general practice that happens to treat some patients with a substance use disorder is not a program on that basis alone.
Federal assistance is broad. Under 42 CFR 2.12(b), a program is federally assisted if, among other tests, it is a "Participating provider in the Medicare program", holds a "Registration to dispense a substance under the Controlled Substances Act to the extent the controlled substance is used in the treatment of substance use disorders", receives federal financial assistance "in any form", or has tax-exempt status.
| Who | Covered by Part 2? | Why |
|---|---|---|
| Outpatient SUD clinic that bills Medicare | Yes | It holds itself out as an SUD program and is federally assisted |
| Opioid treatment program | Yes | It dispenses controlled substances for SUD treatment under a federal registration |
| Private practitioner who advertises SUD treatment | Yes, if federally assisted | The rule names private practitioners who hold themselves out as providing SUD care |
| Identified SUD unit inside a general hospital | Yes | An identified unit that provides SUD care counts as a program |
| Emergency room staff treating an overdose | Usually no | The rule uses this as an example of care it does not cover |
| Primary care or therapy practice that notes a patient's substance use | Usually no | Providers outside Part 2 may record SUD information in their own records |
| Provider, health plan or vendor that receives Part 2 records | In part | Some Part 2 rules follow the records to whoever receives them |
The rule's own examples: coverage includes "private practitioners who hold themselves out as providing, and provide substance use disorder diagnosis, treatment, or referral for treatment", but the rule "would not apply, for example, to emergency room personnel who refer a patient to the intensive care unit for an apparent overdose" (42 CFR 2.12(e)). SAMHSA adds that "Some Part 2 requirements also apply to people and organizations who receive Part 2 records" (SAMHSA).
Which records does 42 CFR Part 2 protect?
Part 2 protects records that would identify a patient as having or having had a substance use disorder and that come from a Part 2 program. The definition of records is wide: "any information, whether recorded or not, created by, received, or acquired by a part 2 program relating to a patient", with examples that include "billing information, emails, voice mails, and texts" (42 CFR 2.11). Former patients are covered too.
Records keep their status when they travel. Records a Part 2 program sends to a provider outside Part 2 "retain their characteristic as records in the hands of the provider who is not subject to this part, but may be segregated by that provider" (42 CFR 2.11). A provider outside Part 2 that writes its own note about a patient's substance use is a different case: the rule says that "does not constitute a record that has been redisclosed under this part" (42 CFR 2.12).
The 2024 rule added SUD counseling notes: notes by a Part 2 provider "documenting or analyzing the contents of conversation during a private SUD counseling session" (or a group, joint or family session) that are kept apart from the rest of the record (42 CFR 2.11). HHS calls this "analogous to protections in HIPAA for psychotherapy notes" (HHS fact sheet); see psychotherapy notes.
What must a 42 CFR Part 2 consent form include?
A Part 2 consent "may be paper or electronic and must include" a fixed list of elements (42 CFR 2.31). In plain terms:
- The patient's name.
- Who may make the use or disclosure: a named person or a class of persons.
- What information, described "in a specific and meaningful fashion".
- Who receives it. For one consent covering treatment, payment and health care operations, the rule accepts "my treating providers, health plans, third-party payers, and people helping to operate this program" or similar wording.
- Each purpose of the use or disclosure.
- The patient's right to revoke the consent in writing, and how to do it.
- An expiration date or an expiration event.
- The patient's signature (or an authorized person's, in some cases) and the date. Electronic signatures are allowed where the law permits.
- For a treatment, payment and operations consent: a statement that records may be redisclosed and "no longer protected by this part", and the consequences of refusing to sign.
Two consents must stand alone. Consent for SUD counseling notes "may only be combined with another written consent for a use or disclosure of SUD counseling notes", and consent to use records in a civil, criminal, administrative or legislative proceeding "cannot be combined with a consent to use and disclose a record for any other purpose" (42 CFR 2.31).
42 CFR Part 2 consent form sample: an annotated outline
This is an illustration written for this page, not a legal form and not any program's real document. It shows how each required element might read in a consent for a fictional outpatient program, called Example Recovery Program here, so you can check your own form against the rule. Have counsel review the form your program actually uses.
| Element (42 CFR 2.31(a)) | Sample wording | What to check |
|---|---|---|
| Patient name | I, [patient name], agree that... | Full legal name, so records can be matched |
| Who discloses | Example Recovery Program and its staff | Name the program, not just "my provider" |
| What information | My diagnosis, treatment dates, medications and attendance records | Specific and meaningful; avoid "all my records" |
| Recipients | My treating providers, health plans, third-party payers, and people helping to operate this program | This wording is allowed for one treatment, payment and operations consent |
| Purpose | For treatment, payment, and health care operations | List each purpose if there are several |
| Right to revoke | I may revoke this consent in writing at any time by writing to the program's privacy officer, except where the program has already acted on it | Say how to revoke |
| Expiration | This consent ends when my treatment ends | "End of the treatment" or "none" is allowed for treatment, payment and operations |
| Redisclosure statement | Records shared under this consent may be shared again by the people who receive them and may no longer be protected by 42 CFR Part 2 | Required in a treatment, payment and operations consent |
| Refusal statement | If I do not sign, [the consequence at this program] | Required in a treatment, payment and operations consent |
| Signature and date | Patient signature and date; a parent or authorized person where the law requires | Electronic signatures allowed where the law permits |
Fictional program and wording, written for this page. SUD counseling notes and any consent for a court case each need a form of their own. For the HIPAA equivalent, see the HIPAA authorization form guide.
How does redisclosure work under 42 CFR Part 2?
Redisclosure means a recipient passing records on again. Each disclosure made with consent must carry a written notice. The long form begins "This record which has been disclosed to you is protected by Federal confidentiality rules (42 CFR part 2)" and warns that "A general authorization for the release of medical or other information is NOT sufficient" for further use or redisclosure. The short form reads: "42 CFR part 2 prohibits unauthorized use or disclosure of these records." Each disclosure must also come with "a copy of the consent or a clear explanation of the scope of the consent provided" (42 CFR 2.32).
The 2024 rule changed what happens next. When a HIPAA covered entity or business associate receives records for treatment, payment or operations, it "may further disclose those records in accordance with the HIPAA regulations, except for uses and disclosures for civil, criminal, administrative, and legislative proceedings against the patient" (42 CFR 2.33). HHS puts it plainly: the entity "can share the record again without consent in all the ways that HIPAA allows, except for using the information in legal proceedings against the patient" (HHS).
Records received under that consent need no silo of their own: the recipient "is not required to segregate or segment such records" (42 CFR 2.12). Every use must still be "limited to that information which is necessary to carry out the purpose of the use or disclosure" (42 CFR 2.13).
What changed in the 2024 Part 2 final rule?
The final rule says: "This final rule is effective on April 16, 2024." and "Persons subject to this regulation must comply with the applicable requirements of this final rule by February 16, 2026." (Federal Register). That date has passed, so the rules on this page apply now. HHS's fact sheet lists the main changes (HHS fact sheet):
- One consent for the future: the rule "Allows a single consent for all future uses and disclosures for treatment, payment, and health care operations."
- Penalties: it "Aligns Part 2 penalties with HIPAA by replacing criminal penalties currently in Part 2 with civil and criminal enforcement authorities that also apply to HIPAA violations."
- Breach notification: the requirements of the HIPAA Breach Notification Rule now apply to Part 2 records.
- Public health: de-identified records may go to public health authorities without consent.
- No silos: the rule "Adds an express statement that segregating or segmenting Part 2 records is not required."
Enforcement moved too: "On August 25, 2025, the HHS Secretary delegated to the Director of the Office for Civil Rights (OCR) the authority to administer and enforce Part 2", and "Beginning on February 16, 2026, anyone can file a Part 2 complaint" (HHS). What did not change: SUD treatment records "cannot be used to investigate or prosecute the patient without written patient consent or a court order" (HHS fact sheet).
42 CFR Part 2 and HIPAA: what is the difference?
Part 2 covers a narrower set of records than HIPAA, with tighter rules, and many programs are subject to both. Under HIPAA, a covered entity "may use or disclose protected health information for treatment, payment, or health care operations" without authorization in most cases (45 CFR 164.506); Part 2 needs written consent. On legal proceedings, HHS calls Part 2's limit "more stringent than the HIPAA standard" (HHS fact sheet).
| Topic | HIPAA Privacy Rule | 42 CFR Part 2 |
|---|---|---|
| Who it covers | HIPAA covered entities and their business associates | Federally assisted SUD programs, and in part anyone who receives their records |
| What it protects | Protected health information of any kind | Records that would identify a patient as having or having had a substance use disorder |
| Treatment, payment and operations | Allowed without the patient's authorization in most cases | Needs written consent; one consent can cover all future uses of this kind |
| Use in legal proceedings against the patient | Allowed in more situations | Needs specific consent or a court order |
| Therapy and counseling notes | Psychotherapy notes need their own authorization | SUD counseling notes need their own consent |
| Breach notification | HIPAA Breach Notification Rule | The same requirements, since the 2024 rule |
| Enforcement | HHS Office for Civil Rights | HHS Office for Civil Rights, since the August 2025 delegation |
| De-identified data | Outside the Privacy Rule when de-identified under 45 CFR 164.514 | Outside Part 2's restrictions when de-identified to the same standard |
Common mistakes with 42 CFR Part 2
Most problems come from guessing whether Part 2 applies.
- Assuming Part 2 covers every chart that mentions substance use. It covers records from federally assisted programs that hold themselves out as providing SUD care.
- Assuming a private practice is outside Part 2. Medicare participation, a DEA registration used for SUD treatment, any federal funds or tax-exempt status can each make it federally assisted.
- Relying on a general medical release. The required notice says a general authorization "is NOT sufficient" for further use or redisclosure.
- Folding SUD counseling notes, or consent for a court case, into the general consent. Both need their own.
- Treating records received from a Part 2 program as ordinary records. They keep their Part 2 status in the recipient's hands.
Can Part 2 records be used outside treatment?
Only through narrow routes while they identify patients: research disclosures follow 42 CFR 2.52, and researchers may publish the data "only in aggregate form". De-identified information is different. In the 2024 rule HHS wrote that Part 2's protections do not extend "to de-identified information, as such information is outside the scope of § 2.12(a)" (Federal Register). Part 2 uses HIPAA's standard for this, 45 CFR 164.514(b), as in its public health rule (42 CFR 2.54).
AI data buyers have asked Origin for behavioral health and specialty care records, as well as longitudinal EHR records (patient records over time with diagnoses, medications, labs and outcomes), imaging with reports (CT, MRI, X-ray and pathology slides) and doctor-patient conversation audio with transcripts. A buyer told Origin that these deals need three pieces of paperwork to get through: de-identification signed off by an independent third party under HIPAA's Expert Determination method, not by the seller; IRB approval, or patient consent that covers commercial licensing; and a clear chain of rights showing who collected the data, who owns it and who can license it.
What must come out first: anything that could identify a patient, including the life details in free-text notes; SUD counseling notes and psychotherapy notes in full; and records received under other providers' consents. See licensing behavioral health records for how Part 2 and HIPAA apply to a practice. Origin is an independent data partner. It does not perform Expert Determination or IRB review. It helps a practice work out what it holds, which of the three requirements it already meets and what is missing. The practice decides what is shared and signs any license itself, and a buyer may pay Origin when a deal closes.
Does your company hold records like these? See what your data is worth.
Common questions
What is 42 CFR Part 2 in simple terms?
42 CFR Part 2 is a federal rule that keeps substance use disorder treatment records confidential. It applies to federally assisted programs that offer SUD diagnosis, treatment or referral, and partly to anyone who receives their records. In most cases the program needs the patient's written consent to share records, and the records cannot be used against the patient in legal proceedings without consent or a court order.
Does 42 CFR Part 2 apply to my practice?
It does if your practice holds itself out as providing substance use disorder diagnosis, treatment or referral and is federally assisted. Federal assistance includes Medicare participation, a DEA registration used for SUD treatment, any federal funds and tax-exempt status. A general or therapy practice that only notes a patient's substance use is usually outside it, but records it receives from a Part 2 program keep their protection.
What is the difference between 42 CFR Part 2 and HIPAA?
HIPAA covers most health information held by covered entities and lets them use it for treatment, payment and operations without authorization. Part 2 covers only SUD records from federally assisted programs and needs written consent for those same uses. Part 2 also bars use in legal proceedings against the patient without specific consent or a court order, which HHS calls more stringent than HIPAA.
When did the 42 CFR Part 2 final rule take effect?
The 2024 final rule took effect on April 16, 2024, and everyone subject to Part 2 had to comply by February 16, 2026. It allowed one consent for all future treatment, payment and operations, aligned penalties and breach notification with HIPAA, created SUD counseling notes with their own consent, and moved enforcement to the HHS Office for Civil Rights.
Is there a 42 CFR Part 2 consent form sample?
The rule sets required elements rather than one official form, and a consent may be paper or electronic. A consent needs the patient's name, who discloses, what information, the recipients, each purpose, the right to revoke, an expiration, the signature and date, and for treatment, payment and operations, redisclosure and refusal statements. Have counsel review the form you use.
What is redisclosure under 42 CFR Part 2?
Redisclosure is a recipient sharing Part 2 records again. Each consented disclosure must carry the Part 2 notice and a copy or explanation of the consent. Since the 2024 rule, HIPAA covered entities and business associates that receive records for treatment, payment or operations may redisclose them as HIPAA allows, except for use in legal proceedings against the patient.
Does 42 CFR Part 2 apply to de-identified data?
No. In the 2024 final rule HHS wrote that de-identified information is outside the scope of the section that sets Part 2's restrictions. Part 2 uses HIPAA's de-identification standard in 45 CFR 164.514(b). Records that can still identify a patient stay protected, and free-text counseling notes are hard to de-identify, so an expert usually reviews them.
Who enforces 42 CFR Part 2?
The HHS Office for Civil Rights. The HHS Secretary delegated authority to administer and enforce Part 2 to the OCR Director on August 25, 2025. OCR can run compliance reviews, investigate complaints and impose civil money penalties, and since February 16, 2026 anyone can file a Part 2 complaint. Part 2 programs must also report breaches of unsecured Part 2 records.
Sources and further reading
- eCFR: 42 CFR 2.11, Definitions
- eCFR: 42 CFR 2.12, Applicability
- eCFR: 42 CFR 2.31, Consent requirements
- eCFR: 42 CFR 2.32, Notice and copy of consent to accompany disclosure
- eCFR: 42 CFR 2.33, Uses and disclosures permitted with written consent
- eCFR: 42 CFR 2.2, Purpose and effect
- eCFR: 42 CFR 2.13, Confidentiality restrictions and safeguards
- eCFR: 42 CFR 2.52, Scientific research
- eCFR: 42 CFR 2.54, Disclosures for public health
- Federal Register: Confidentiality of Substance Use Disorder (SUD) Patient Records, final rule (2024)
- SAMHSA: Substance Use Disorders, Statutes, Regulations, and Guidelines
- HHS: Understanding Confidentiality of Substance Use Disorder (SUD) Patient Records or "Part 2"
- HHS: Fact Sheet, 42 CFR Part 2 Final Rule
- eCFR: 45 CFR 164.506, Uses and disclosures for treatment, payment, or health care operations
